Table 8.
Summary of additives added to cardioplegia solutions at centers where individual respondents worked.
| Additive Used | Glucose | Calcium Channel Blocker | THAM | Aspartate | Glutamate | Other | No Response |
|---|---|---|---|---|---|---|---|
| Europe | 7 (17.9%) | 3 (7.7%) | 8 (20.5%) | 9 (23.1%) | 7 (18.0%) | 6 (15.4%) | 230 (85.5%) |
| North America | 56 (53.3%) | 8 (7.6%) | 22 (21.0%) | 20 (19.1%) | 27 (25.7%) | 28 (26.7%) | 229 (68.6%) |
| ANZ | 7 (16.7%) | 1 (2.4%) | 1 (2.4%) | 23 (54.8%) | 8 (19.1%) | 9 (21.4%) | 61 (58.1%) |
| South America | 19 (40.4%) | 9 (19.1%) | 2 (4.3%) | 6 (12.8%) | 7 (14.9%) | 11 (23.4%) | 168 (78.1%) |
| Total | 89 (38.2%) | 21 (9.0%) | 33 (14.2%) | 58 (24.9%) | 49 (21.0%) | 54 (23.2%) | 688 (74.5%) |
Percentage values relate to proportion providing a response to the question. Respondents could select more than one answer. The far right column indicates the overall proportion not answering the question. p-value < .001, chi squared test. THAM, tris-hydroxymethyl aminomethane. All tablulated values: number (percentage).